Navigation Links
NW Bio Provides Guidance On Phase III Trial Enrollment Timing: Completion Expected To Be Faster Or More Efficient Than Relevant Comparison Trials
Date:3/7/2013

li>Agenus, Inc. (NASDAQ: AGEN) is conducting a Phase II trial with 55 patients, which began recruiting in Q2, 2009 and stopped recruiting in Q2, 2012.

NW Bio has primarily been enrolling its Phase III trial since Q2 of 2011.  The Company undertook a limited period of enrollment in 2008, and then kept the trial going with the patients already enrolled, but suspended new enrollment due to resource constraints during the worst of the economic downturn, through the end of 2010.  The Company began the process of reactivating clinical trial sites for new enrollment in Q1 2011, and resumed screening in Q2 of 2011.

NW Bio expects to complete enrollment in its phase III trial by Q1 or early Q2 of next year – an overall enrollment period of 14 or 15 calendar quarters, including both the 2008 period and the period since Q2 2011. 

This represents a rate of enrollment that compares as follows with Celldex, IMUC and Agenus: Total Trial

 Enrollment

Enrollment

Period

Pace of Enrollment to

Completion, Based On

Enrollment Period 

NW Bio

Ph. III

 

312 patients

14 quarters or

15 quarters

22.3 patients per quarter or

20.8 patients per quarter 

IMUC

Ph. II

 

124 patients

7 quarters

17.7 patients per quarterCelldex

Ph. III

440 patients

≥16 quarters [est.]

 

27.5 patients per quarter*

 

*[164 clinical trial sites worldwide]

  

Agenus

Ph. II

 

55 patients

12 quarters

4.6 patients per quarterNotably, even if the completion of NW Bio's Phase III trial enrollment were to take substantially longer than the Company's projection of Q1 or early Q2 20
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Medical Alarm Concepts Provides Investor Update - Signs Deal with Health Care Insurance Provider for Medical Alarms
2. Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
3. Compass Diversified Holdings Provides Shareholders with 2012 Tax Information
4. Volcano Corporation Provides Additional Guidance For 2013
5. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
6. AcelRx Pharmaceuticals Provides Clinical Trial Updates
7. Masimo Reports Fourth Quarter and Full Year 2012 Financial Results; Provides 2013 Financial Guidance
8. US Peptides Provides New Article Discussing HGH and Athletic Performance
9. BioMed Realty Trust Provides Notice of Redemption of 7.375% Series A Cumulative Redeemable Preferred Stock
10. Genomic Health Announces Year-End 2012 Financial Results, Provides 2013 Financial Outlook
11. Breakthrough Procedure Provides Relief for Acid Reflux
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... -- Georgia-Pacific Professional is a leading provider of hygienic ... range of away from home applications. Building on ... including hospitals, long-term care facilities, surgical centers and ... products and solutions to the dental community. ... control in the dental office," said Sean ...
(Date:9/30/2014)... BURLINGTON, Mass. , Sept. 30, 2014 /PRNewswire/ ... of U.S. patient-level claims data, anemic chronic kidney ... with their erythropoiesis-stimulating agent (ESA) medication. In addition, ... Janssen,s Procrit. Other key findings ... in Nephrology: An Analysis of Erythropoiesis Stimulating Agents ...
(Date:9/30/2014)... Sept. 30, 2014   Acutus Medical, ... invasive real-time 3D Cardiac Chamber Imaging and Dipole Density ... / or sustain complex cardiac arrhythmias, including atrial fibrillation, ... continue developing its imaging/mapping system as well as bring ... allow Acutus Medical to complete work on the AcQMap ...
Breaking Medicine Technology:Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 2Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 3Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 2Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 3Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 2Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 3
... 23 OrbusNeich today announced that six-month follow-up ... and efficacy of the company,s Genous Bio-engineered R ... the treatment of de novo coronary artery disease. ... University of Ulm, Germany, principal investigator of the ...
... DEERFIELD, Ill. and LONDON, Sept. 23 Following today’s ... and the European Medicines Agency (EMA) for rosiglitazone in ... and Takeda Pharmaceuticals Europe Limited (“Takeda”) underscore the company’s ... medications, and to the millions of people living with ...
Cached Medicine Technology:OrbusNeich's Genous™ Bio-engineered R stent™ Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease 2OrbusNeich's Genous™ Bio-engineered R stent™ Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease 3Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S. 2Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S. 3Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S. 4
(Date:9/30/2014)... 2014 Keystone Symposia will convene the first conference ... 2014-15 Global Health Series on "The Modes of ... immediately following the conclusion of the Grand Challenges ... part of the Keystone Symposia Global Health Series, supported ... also funded travel awards for 36 investigators from developing ...
(Date:9/30/2014)... Shrewsbury, NJ (PRWEB) September 30, 2014 ... health and wellness, is opening another new medical specialty ... group. IMA Cardiology will be located within ... Dr. Ziad Abbud and Dr. Isaac Tawfik of American ... Neptune, N.J. The new practice will offer Integrated Medicine ...
(Date:9/30/2014)... University of Maryland-led research team has been awarded ... Institutes of Health (NIH) to develop new imaging ... our understanding of how large networks of neurons ... This knowledge will help researchers identify the precise ... behavior, like decision-making and speaking, and alterations in ...
(Date:9/30/2014)... Vegas, NV (PRWEB) September 30, 2014 ... is helping people perform better in and out of the ... and memory has caught the attention of Shane Michaels, prompting ... day-to-day grind, fatigue is the reason most people simply just ... whether that means staying focused at work, getting the motivation ...
(Date:9/30/2014)... Hospice & Palliative Care of ... gala, honoring three outstanding individuals for their commitment ... provide extraordinary and dignified comfort, care and compassion ... life-limiting illness. , The event was held at ... recognized William (Bill) J. McGuinness, Director of Tiffany ...
Breaking Medicine News(10 mins):Health News:Keystone Symposia launches 2014-2015 meeting series with Global Health Vaccines Conference 2Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2
... New York City to Meet Breslin, ... in Need During the Holidays, BETHEL, Conn., Oct. 19 ... search for Duracell Holiday,Ambassadors to help "Power A Smile" this ... for her Academy Award,nominated role in "Little Miss Sunshine," to ...
... Fla., Oct. 19 Allergan (AGN) has,entered into a ... specialty training for aesthetic medicine and surgery. According,to Dr. ... that the right,type of training is provided to the ... type of long term agreement is a milestone for ...
... The SCOOTER,Store ( http://www.thescooterstore.com/aboutus/ ) ... Award from Runzheimer International for the ... cited for an outstanding program of,managing ... helped make,the nation,s largest supplier of ...
... part of country most affected , , FRIDAY, Oct. ... staph germ called MRSA are approaching epidemic levels ... federal epidemiologist says. , Methicillin-resistant Staphylococcus aureus infections, ... an estimated 12 million outpatient visits each year ...
... by YouthAIDS:, WHAT: In March 2007, YouthAIDS Global Ambassador, acclaimed ... Judd teamed up with Bollywood ... explore how HIV travels from high-risk groups to the general ... women are increasingly at risk for ...
... An ever-changing U.S. consumer who enjoys the convenience of ready-to-eat ... brought new challenges to food import safety, experts said Oct. ... than $2 trillion this year and expected to triple by ... met at Texas A&M University to discuss ways to strengthen ...
Cached Medicine News:Health News:Duracell and Actress Abigail Breslin Search for Holiday Ambassadors 2Health News:Duracell and Actress Abigail Breslin Search for Holiday Ambassadors 3Health News:The Scooter Store Wins Second Consecutive 'Best Practices' Award From Runzheimer International 2Health News:Drug-Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U.S. 2Health News:Drug-Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U.S. 3Health News:Drug-Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U.S. 4Health News:National Geographic Channel, Ashley Judd and YouthAIDS Host World Premiere Screening of 'India's Hidden Plague' 2Health News:Consumer demand flavors food import safety issues 2
... doctors, tests for elevated thyroid stimulating hormone ... the first clinical indicator of hypothyroidism. , ... to use, cost effective and accurate. ... programs and health promotion. , ThyroChek is CLIA ...
VertiGraft allografts for spine surgery deliver the strength adn performance you demand in your procedures and they are backed by quality and safety standards that are unmatched in the industry....
... hip retractor system provides ... total hip replacement. Fully ... surgeon techniques on any ... Hand-held retractors can easily ...
... flexibility for every general surgery need. No ... patient, the GO550/GO500 Omni-Flex General Retractor Systems ... the simplest way possible., ,With large and ... extension arm, the GO550 provides comprehensive flexibility ...
Medicine Products: